Saint Charles Health System-Redmond — Redmond, Oregon

Saint Charles Health System-Redmond is a clinical research site located in Redmond, Oregon, United States 97756.

Crixeo Clinical Trials Trust Score: 32/100 (FAILING). This profile has not yet been claimed by the site owner.

Saint Charles Health System-Redmond has participated in 134 clinical trials with 106 currently active.

Therapeutic areas: Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Sponsors: National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology, ECOG-ACRIN Cancer Research Group.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Redmond

Browse all research sites in Oregon · View every site in Redmond

Sponsor Feasibility Report

Trust Score: 32/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Charles Health System-Redmond?

Saint Charles Health System-Redmond has a Crixeo Trust Score of 32/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Charles Health System-Redmond conducted?

Saint Charles Health System-Redmond has 134 clinical trials on record, with 106 currently active. Their work covers Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7, Unresectable Melanoma.

Is Saint Charles Health System-Redmond accredited by Crixeo Clinical Trials?

Saint Charles Health System-Redmond has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Saint Charles Health System-Redmond?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.